Imricor Expands Middle East Footprint Into Qatar

21 December 2023 – Minneapolis, United StatesImricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce it has entered into a Distribution Agreement with East Agency WWL, Firm of the Holding (East Agency), a prominent distributor in Qatar. Under the terms of this 5-year agreement, East Agency will be the exclusive distributor of Imricor’s products in Qatar.

This marks another major achievement for Imricor as it enters a new Middle East country, following the Kingdom of Saudi Arabia earlier this year, bringing the first and only iCMR family of ablation products to healthcare professionals and patients in Qatar.

East Agency’s CEO, Mohamed Mekky, said: “We at East Agency are very thrilled to sign a partnership agreement with Imricor.  We believe that this partnership will be a game changer in ablation procedures here in Qatar, especially after the great feedback and strong interest in adopting this technology we had from the largest Cardiac Centres here in Doha.”

Imricor’s collaboration with East Agency underscores its commitment to expansion and continued growth in strategic markets.

Imricor’s Chair and CEO, Steve Wedan, said: “We are extremely pleased to partner with East Agency, and we look forward to offering real-time iCMR cardiac ablations to patients and physicians in Qatar soon. This is just the latest step in growing our global footprint, and we intend to continue expanding in the Middle East with additional countries over time.”

~ ~ ~ ~ ~
About Imricor